Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the unaudited standalone & consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Limited has informed BSE that its Board of Directors will meet on Tuesday, 11 November 2025, at its Delhi office. The main agenda item is to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30 September 2025 (Q2/H1 FY26). Any other business with the Chair's permission may also be taken up. The company also reiterated that the trading window for designated persons has been closed since 1 July 2025 and will remain closed until 48 hours after the results are declared, in line with insider trading regulations.
This is a routine pre-results intimation and does not contain any financial numbers or business updates, so it is unlikely to move the stock on its own. Investors should watch 11 November for the actual Q2/H1 FY26 numbers, which could be a near-term catalyst.